Tony Griffin stepping down as Dechra executive director
27th Nov 2023 08:31
(Sharecast News) - Dechra Pharmaceuticals announced the departure of one of its longstanding executives, Tony Griffin, on Monday.
Read moreDechra delivers 'resilient' year as EQT buyout nears completion
12th Oct 2023 07:52
(Sharecast News) - London-listed veterinary pharmaceuticals group Dechra, which will soon be taken private after a buyout by Sweden's EQT, said on Thursday it delivered a "resilient" performance in the year to 30 June.
Read moreDechra to be taken private in £4.5bn deal
2nd Jun 2023 07:02
(Sharecast News) - Dechra Pharmaceuticals said on Friday that it has agreed to be taken over in a £4.46bn deal.
Read moreDechra warns on profits after volatile third quarter
22nd May 2023 07:43
(Sharecast News) - Animal health specialist Dechra Pharmaceuticals issued a profit warning on Monday morning, saying that the trading environment since January had been more volatile and challenging than it previously expected.
Read moreEQT bid deadline for Dechra Pharmaceuticals pushed back
11th May 2023 11:58
(Sharecast News) - Dechra Pharmaceuticals said on Thursday that a deadline for Swedish private firm EQT to either announce a firm intention to make an offer for the company or walk away has been extended.
Read moreDechra Pharmaceuticals surges on £4.6bn takeover approach
14th Apr 2023 10:00
(Sharecast News) - Shares in Dechra Pharmaceuticals surged on Friday after it announced late on Thursday that it was in talks with Swedish private equity firm EQT about a possible £4.6bn takeover.
Read moreDechra Pharmaceuticals in takeover talks with PE firm EQT
13th Apr 2023 17:40
(Sharecast News) - Dechra Pharmaceuticals confirmed on Thursday that it has entered into discussions with private equity firm EQT about a possible all-cash recommended offer for the company.
Read moreDechra profits tumble despite revenue improvement
27th Feb 2023 07:30
(Sharecast News) - Shares in Dechra slumped on Monday after the veterinary pharmaceuticals company issued a profits warning and reported a fall in half-year earnings.
Read moreDechra Pharmaceuticals H1 revenues rise
12th Jan 2023 08:02
(Sharecast News) - Veterinary drugs group Dechra Pharmaceuticals said on Thursday that interim revenues had grown despite "a very tough" prior year comparator.
Read moreDechra on track despite weaker first quarter
20th Oct 2022 07:02
(Sharecast News) - Dechra Pharmaceuticals said on Thursday it remained on course to meet full-year expectations, despite a slower start to the year.
Read moreBerenberg starts Dechra at 'hold', highlights 'plenty of pet-ential'
5th Oct 2022 10:12
(Sharecast News) - Berenberg initiated coverage of veterinary pharmaceuticals group Dechra Pharmaceuticals with a 'hold' rating and 2,850p price target, saying it has "plenty of pet-ential".
Read moreRBC Capital Markets lowers target price on Dechra Pharmaceuticals
15th Sep 2022 09:01
(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on veterinary drugmaker Dechra Pharmaceuticals from 4,200.0p to 4,000.0p on Thursday following the group's full-year results a week earlier.
Read moreDechra Pharmaceuticals FY revenues and profits rise
5th Sep 2022 07:01
(Sharecast News) - Veterinary pharmaceuticals group Dechra said on Monday that both revenues and profits had risen throughout the twelve months ended 30 June.
Read moreDechra Pharmaceuticals buys California-based Med-Pharmex for $260m
30th Aug 2022 07:53
(Sharecast News) - Dechra Pharmaceuticals said on Tuesday that it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex for $260m (£221.5m).
Read moreDechra raises £180m in discounted placing for Piedmont deal
21st Jul 2022 09:26
(Sharecast News) - Dechra Pharmaceuticals slumped on Thursday after the animal drug maker raised around £180m in a discounted share placing for the acquisition of US-based Piedmont Animal Health.
Read more